BioNetwork 2022

TBD

Past Speakers (2019)

Robert Bagdorf, VP & Group Lead, Search and Evaluation, Worldwide Business Development at Pfizer Inc.

Robert Bagdorf

VP & Group Lead, Search and Evaluation, Worldwide Business Development
Pfizer Inc.

Laszlo Kiss, Executive Director, WRD and Principal at Pfizer Ventures

Laszlo Kiss

Executive Director, WRD and Principal
Pfizer Ventures

Jennifer Leeds, Head, West Coast Search and Evaluation at Novartis

Jennifer Leeds

Head, West Coast Search and Evaluation
Novartis

David Morris, Managing Director at Novartis Venture Fund

David Morris

Managing Director
Novartis Venture Fund

Vanitha Sekar, Executive Director, Business Development & Licensing at Merck Research Labs

Vanitha Sekar

Executive Director, Business Development & Licensing
Merck Research Labs

Michal Preminger, Head, Johnson & Johnson Innovation, East North America at Johnson & Johnson

Michal Preminger

Head, Johnson & Johnson Innovation, East North America
Johnson & Johnson

Niels Emmerich, VP, Global Head Search & Evaluation at Abbvie

Niels Emmerich

VP, Global Head Search & Evaluation
Abbvie

Anna Maroney, Vice President, Corporate Strategy Office, Head, Alliance Management at AbbVie

Anna Maroney

Vice President, Corporate Strategy Office, Head, Alliance Management
AbbVie

KT Moortgat, Director at AbbVie Ventures

KT Moortgat

Director
AbbVie Ventures

Monica Viziano, Executive Director, Alliance Management at Gilead

Monica Viziano

Executive Director, Alliance Management
Gilead

Chris Sheldon, Head of Oncology Search and Evaluation at AstraZeneca

Chris Sheldon

Head of Oncology Search and Evaluation
AstraZeneca

Michael Andrew Johnson, VP, Business Development at Eli Lilly

Michael Andrew Johnson

VP, Business Development
Eli Lilly

Jak Knowles, Vice President, Venture Investments at Bayer

Jak Knowles

Vice President, Venture Investments
Bayer

Wesley Galamb, US Lead, Business Development & Innovation at Novo Nordisk

Wesley Galamb

US Lead, Business Development & Innovation
Novo Nordisk

Don Frail, SVP, Research, External Science & Innovation at Allergan

Don Frail

SVP, Research, External Science & Innovation
Allergan

Jonathan York, VP, Global Business Development at Daiichi Sankyo

Jonathan York

VP, Global Business Development
Daiichi Sankyo

Nouhad Husseini, Vice President, Head of Business Development at Regeneron Pharmaceuticals

Nouhad Husseini

Vice President, Head of Business Development
Regeneron Pharmaceuticals

Melissa Fitzgerald, Head of Oncology Search & Evaluation at Halozyme Therapeutics

Melissa Fitzgerald

Head of Oncology Search & Evaluation
Halozyme Therapeutics

Jordan Zwick, Senior Director, Strategy at Salix Pharmaceuticals

Jordan Zwick

Senior Director, Strategy
Salix Pharmaceuticals

Kent Rogers, SVP, Industry Relations at OptumRx

Kent Rogers

SVP, Industry Relations
OptumRx

Joe Whalen, Senior Vice President, Business Development and Alliance Management at Horizon Therapeutics

Joe Whalen

Senior Vice President, Business Development and Alliance Management
Horizon Therapeutics

Ron Alfa, Senior Vice President of Translational Discovery & Chief Evangelist at Recursion Pharma

Ron Alfa

Senior Vice President of Translational Discovery & Chief Evangelist
Recursion Pharma

Nina Kjellson, General Partner at Canaan

Nina Kjellson

General Partner
Canaan

Steve Hsu, SVP, Office of Research and Innovation at Michigan State University

Steve Hsu

SVP, Office of Research and Innovation
Michigan State University

Neena Kadaba, Director, Science at Quark Venture

Neena Kadaba

Director, Science
Quark Venture

Alan Koncarevic, Director, Industry Relations; Head, Strategic Alliances at University of Chicago

Alan Koncarevic

Director, Industry Relations; Head, Strategic Alliances
University of Chicago

Abhijit Banerjee, Senior Director, Business Development at Oregon Health & Science University

Abhijit Banerjee

Senior Director, Business Development
Oregon Health & Science University

Roland Buelow, CEO at TeneoBio

Roland Buelow

CEO
TeneoBio

Ashim Subedee, Program Director at NCI Small Business Innovation Research (SBIR) Development Center

Ashim Subedee

Program Director
NCI Small Business Innovation Research (SBIR) Development Center

Jonathan Gertler, Managing Partner & CEO at Back Bay Life Science Advisors

Jonathan Gertler

Managing Partner & CEO
Back Bay Life Science Advisors

Michael O'Donnell, Partner at Morrison & Foerster

Michael O'Donnell

Partner
Morrison & Foerster

Jeff Elton, Chief Executive Officer at Concerto Health AI

Jeff Elton

Chief Executive Officer
Concerto Health AI

Amy DuRoss, Co-founder and CEO at Vineti

Amy DuRoss

Co-founder and CEO
Vineti

Pablo Cagnoni, CEO at Rubius (and BoD member, CRISPR)

Pablo Cagnoni

CEO
Rubius (and BoD member, CRISPR)

Lawrence Klein, Chief Business Officer at CRISPR Therapeutics

Lawrence Klein

Chief Business Officer
CRISPR Therapeutics

Peter Olagunju, VP, Global Patient Operations at bluebird bio

Peter Olagunju

VP, Global Patient Operations
bluebird bio

Kosta Kleyman, CAR-T Marketing Launch & Strategy Leader at Celgene/Juno

Kosta Kleyman

CAR-T Marketing Launch & Strategy Leader
Celgene/Juno

Brinda Balakrishnan, Group Vice President, Business and Corporate Development at BioMarin Pharmaceuticals

Brinda Balakrishnan

Group Vice President, Business and Corporate Development
BioMarin Pharmaceuticals

Christopher Leo, Senior Vice President at Back Bay Life Science Advisors

Christopher Leo

Senior Vice President
Back Bay Life Science Advisors

Lisa Conte, Founder, President and Chief Executive Officer at Jaguar Health

Lisa Conte

Founder, President and Chief Executive Officer
Jaguar Health

Isaac Bright, Co-Founder and Chief Executive Officer at RubrYc Therapeutics

Isaac Bright

Co-Founder and Chief Executive Officer
RubrYc Therapeutics

Matt Millman, Life Science Research Director at BioNetwork 2019

Matt Millman

Life Science Research Director
BioNetwork 2019

Syed Kazmi, Global Head, Business Development & Licensing, Oncology at Novartis

Syed Kazmi

Global Head, Business Development & Licensing, Oncology
Novartis

Kate Rittenhouse-Olson, Founder at For-Robin, Inc

Kate Rittenhouse-Olson

Founder
For-Robin, Inc

Ravi Srinivasan

Founder, President, CEO
OncoNano Medicine

Jeff Davidson, Chief Executive Officer at Keystone Nano

Jeff Davidson

Chief Executive Officer
Keystone Nano

Manijeh Goldberg

Founder & CEO
Privo Technologies

Judith Hasko

Partner
Latham & Watkins

Vasiliki Anest, Senior Director, Business Development and Industry Relations at Keck School of Medicine of USC

Vasiliki Anest

Senior Director, Business Development and Industry Relations
Keck School of Medicine of USC

Hemmie Chang, Chair, Licensing & Strategic Alliances Practice Group at Foley Hoag

Hemmie Chang

Chair, Licensing & Strategic Alliances Practice Group
Foley Hoag

Jane Rhodes, Chief Business Officer at Verge Genomics

Jane Rhodes

Chief Business Officer
Verge Genomics

Lori Hazlehurst, CEO at Modulation Therapeutics

Lori Hazlehurst

CEO
Modulation Therapeutics

Hannah Cabot, Associate M&A at Back Bay Life Science Advisors

Hannah Cabot

Associate M&A
Back Bay Life Science Advisors

Scott Shaunessy, CEO at ideaPoint

Scott Shaunessy

CEO
ideaPoint

Nick Galli, Chief Business Officer at CytomX

Nick Galli

Chief Business Officer
CytomX

Winny Tan, Senior Manager, Strategic Alliances at IMEC

Winny Tan

Senior Manager, Strategic Alliances
IMEC

Mark Mendel, Business Development Advisor at Syntrix Biosystems

Mark Mendel

Business Development Advisor
Syntrix Biosystems

Mukul Agarwal

Corporate Development Vice President
Forty Seven, Inc.

Spyro Mousses

CEO
Systems Oncology

Jon Barry, Senior Vice President at Back Bay Life Science Advisors

Jon Barry

Senior Vice President
Back Bay Life Science Advisors

Bill Comer

Chairman and CEO
Neurogenetic

We're always looking ahead to book a roster of inspiring speakers. Contact us today to reserve your spot.

Want to see who spoke previously? View the list here.